Biomarkers for the Progression of Intermediate Age-Related Macular Degeneration

Biomarkers for the Progression of Intermediate Age-Related Macular Degeneration

Abstract Age-related macular degeneration (AMD) is a leading cause of severe vision loss worldwide, with a global prevalence that is predicted to substantially increase. Identifying early biomarkers indicative of progression risk will improve our ability to assess which patients are at greatest risk...

Szczegółowa specyfikacja

Opis bibliograficzny
Główni autorzy:	Eleonora M. Lad, Robert P. Finger, Robyn Guymer
Format:	Artykuł
Język:	English
Wydane:	Adis, Springer Healthcare 2023-09-01
Seria:	Ophthalmology and Therapy
Hasła przedmiotowe:	Age-related macular degeneration Biomarkers iAMD Geographic atrophy Neovascular AMD
Dostęp online:	https://doi.org/10.1007/s40123-023-00807-9

Podobne zapisy

Patterns of Gene Expression, Splicing, and Allele-Specific Expression Vary among Macular Tissues and Clinical Stages of Age-Related Macular Degeneration
od: Treefa Shwani, i wsp.
Wydane: (2023-11-01)

Age-Related Macular Degeneration: Classification and Pathogenesis
od: İmren Akkoyun
Wydane: (2014-12-01)

Current and Novel Therapeutic Approaches for Treatment of Neovascular Age-Related Macular Degeneration
od: Reem H. ElSheikh, i wsp.
Wydane: (2022-11-01)

Serum lipids in adults with late age-related macular degeneration: a case-control study
od: Richard D. Semba, i wsp.
Wydane: (2019-01-01)

Off-Label Use of Bevacizumab in Patients Diagnosed with Age-Related Macular Degeneration: A Systematic Review and Meta-Analysis
od: João Estarreja, i wsp.
Wydane: (2024-07-01)

Genetics and Age-Related Macular Degeneration: A Practical Review for Clinicians
od: Julia Nguyen, i wsp.
Wydane: (2024-02-01)

Potential Therapeutic Candidates for Age-Related Macular Degeneration (AMD)
od: Sonali Nashine
Wydane: (2021-09-01)

Age-Related Macular Degeneration: Therapeutic Strategies and Future Approaches
od: Răzvan Vasile ROPCIUC
Wydane: (2024-05-01)

A comprehensive review on early detection of drusen patterns in age-related macular degeneration using deep learning models
od: Kiruthika M, i wsp.
Wydane: (2025-02-01)

Global Insights from Patients, Providers, and Staff on Challenges and Solutions in Managing Neovascular Age-Related Macular Degeneration
od: Anat Loewenstein, i wsp.
Wydane: (2024-12-01)

Role of Complement in the Onset of Age-Related Macular Degeneration
od: Niloofar Piri, i wsp.
Wydane: (2023-05-01)

The Role of Inflammation in Age-Related Macular Degeneration—Therapeutic Landscapes in Geographic Atrophy
od: Grace A. Borchert, i wsp.
Wydane: (2023-08-01)

Etiopathogenesis of non-exudative age-related macular degeneration (literature review)
od: M. M. Bikbov, i wsp.
Wydane: (2022-03-01)

Plasma Metabolites Associated with OCT Features of Age-Related Macular Degeneration
od: Ines Lains, MD, PhD, i wsp.
Wydane: (2024-01-01)

Cost-effectiveness analysis of brolucizumab versus aflibercept for the treatment of neovascular age-related macular degeneration (nAMD) in Italy
od: Nicola Ferrante, i wsp.
Wydane: (2022-04-01)

Early and intermediate age-related macular degeneration: update and clinical review
od: García-Layana A, i wsp.
Wydane: (2017-10-01)

Prevalence of insomnia and depression in patients with age-related macular degeneration
od: Elżbieta Nowak, i wsp.
Wydane: (2018-07-01)

Plasma Metabolomics of Intermediate and Neovascular Age-Related Macular Degeneration Patients
od: Sabrina L. Mitchell, i wsp.
Wydane: (2021-11-01)

Intravitreal Brolucizumab in Patients with Aflibercept-Resistant Neovascular Age-Related Macular Degeneration
od: Ashwin Gupta, i wsp.
Wydane: (2022-01-01)

Eye Drop with Fas-Blocking Peptide Attenuates Age-Related Macular Degeneration
od: Yujong Yi, i wsp.
Wydane: (2024-03-01)

Dry and neovascular “wet” age-related macular degeneration: Upcoming therapies
od: Audrey Yan, i wsp.
Wydane: (2025-01-01)

Linking Adiponectin and Its Receptors to Age-Related Macular Degeneration (AMD)
od: Mayank Choubey, i wsp.
Wydane: (2023-11-01)

Efficacy and safety of brolucizumab versus aflibercept in patients with neovascular age-related macular degeneration: a randomized trial in Indian patients
od: Sanjay Kumar Mishra, i wsp.
Wydane: (2022-07-01)

Antioxidants in Age-Related Macular Degeneration: Lights and Shadows
od: Uday Pratap Singh Parmar, i wsp.
Wydane: (2025-01-01)

Genetic Insights into Age-Related Macular Degeneration
od: Bhumika, i wsp.
Wydane: (2024-07-01)

Safety and efficacy of Razumab™ (world’s first biosimilar ranibizumab) in wet age-related macular degeneration: a post-marketing, prospective ASSET study
od: Shashikant Sharma, i wsp.
Wydane: (2021-03-01)

Retinal Progression Biomarkers of Early and Intermediate Age-Related Macular Degeneration
od: Rita Flores, i wsp.
Wydane: (2021-12-01)

Berries and Their Active Compounds in Prevention of Age-Related Macular Degeneration
od: Xiang Li, i wsp.
Wydane: (2024-12-01)

Dietary and Lifestyle Factors Modulate the Activity of the Endogenous Antioxidant System in Patients with Age-Related Macular Degeneration: Correlations with Disease Severity
od: Zofia Ulańczyk, i wsp.
Wydane: (2020-10-01)

Oxidative Stress, Persistent Inflammation and Blood Coagulation Alterations in Serum Proteome of Patients with Neovascular Age-Related Macular Degeneration
od: Mateusz Winiarczyk, i wsp.
Wydane: (2024-05-01)

Novel Epigenetic Clock Biomarkers of Age-Related Macular Degeneration
od: Saurav Mallik, i wsp.
Wydane: (2022-06-01)

Efficacy and Safety of Nutraceutical Support in Age-Related Macular Degeneration Patients
od: S. V. Yanchenko, i wsp.
Wydane: (2023-01-01)

Deep Learning Approach for Age-related Macular Degeneration Detection Using Retinal Images: Efficacy Evaluation of Different Deep Learning Models
od: Ngoc Thien Le, i wsp.
Wydane: (2023-12-01)

A prospective, randomized, parallel group, double blind, multicenter study to compare the efficacy, safety and immunogenicity of Lupin's Ranibizumab with Lucentis® in patients with neovascular age-related macular degeneration
od: Ramandeep Singh, i wsp.
Wydane: (2022-01-01)

Treatment Strategies for Anti-VEGF Resistance in Neovascular Age-Related Macular Degeneration by Targeting Arteriolar Choroidal Neovascularization
od: Yingbin Fu, i wsp.
Wydane: (2024-02-01)

Case Series on Initial Responses to Intravitreal Brolucizumab in Patients with Recalcitrant Chronic Wet Age-Related Macular Degeneration
od: Avaylon J, i wsp.
Wydane: (2020-05-01)

Geographic Atrophy after Reabsorption of Pigment Epithelial Detachment (GARPED) study
od: Enoch T. Peng, i wsp.
Wydane: (2023-05-01)

Exploring the role of granzyme B in subretinal fibrosis of age-related macular degeneration
od: Karanvir Gill, i wsp.
Wydane: (2024-07-01)

Anatomical and functional responses to single brolucizumab injection in neovascular age-related macular degeneration patients not responding to antiangiogenics: a case series
od: Silvio Zuccarini, i wsp.
Wydane: (2022-03-01)

Genetic Association between MMP9 and Choroidal Neovascularization in Age-Related Macular Degeneration
od: Elliott H. Sohn, MD, i wsp.
Wydane: (2021-03-01)